Tinnitus Quest Launches to Find a Cure for Hearing Disorder Affecting Millions

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Tinnitus-Quest

More Like This

PR Newswire associated0

Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device

PR Newswire associated0

Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus

PR Newswire associated0

Real World Data Supports Lenire Tinnitus Treatment Effectiveness Shown in Large-Scale Clinical Trials

PR Newswire associated0

TYMPAHEALTH CELEBRATES WORLD HEARING DAY WITH A CALL TO ACTION FOR EAR AND HEARING HEALTH: DON'T WAIT, HEAR CLEAR

PR Newswire associated0

Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device Lenire Published in Nature Communications

Investors in the current financing round with AudioCure Management. From left to right: Philipp Zöller (CEO InfectoPharm), Prof Hans Rommelspacher (founder AudioCure), Dr Reimar Schlingensiepen (CEO AudioCure), Dr Ingeborg Hochmair (CEO MED-EL) and Dr Christian Kannemeier (Senior Investment Manager HTGF). Copyright: AudioCure.

InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy

PR Newswire associated0

Neuromod Closes €10 Million Financing to Accelerate Commercialisation

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study